Medicare Enrolled
Dr. Alexander Gevorgyan, M.D.
Clinical Neurophysiology Physician · Glendale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gevorgyan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gevorgyan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gevorgyan
Dr. Alexander Gevorgyan is a clinical neurophysiology physician in Glendale, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Gevorgyan performed 3,913 Medicare services across 2,782 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gevorgyan received a total of $13,012 from 66 pharmaceutical and/or device companies across 409 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in clinical neurophysiology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gevorgyan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 9% volume in CA
$13,012 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,913
Medicare services
Top 9% in CA for clinical neurophysiology physician
2,782
Unique beneficiaries
$115
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~301 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
659 | $109 | $430 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
601 | $89 | $355 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
396 | $79 | $301 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
224 | $31 | $209 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
202 | $13 | $48 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
195 | $141 | $554 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
194 | $156 | $592 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
189 | $190 | $775 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 162 | $68 | $268 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
161 | $33 | $248 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
153 | $360 | $1,345 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
115 | $178 | $676 |
| New patient office visit, complex (60-74 min) | 114 | $190 | $724 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
55 | $0 | $15 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
53 | $80 | $301 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
52 | $222 | $894 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
49 | $225 | $902 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
48 | $237 | $619 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
48 | $120 | $313 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
47 | $238 | $932 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
34 | $158 | $614 |
| Head repositioning exercises for dizziness A series of exercises performed to reposition the head, used to treat dizziness. The procedure is administered on a daily basis. |
30 | $38 | $144 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
30 | $108 | $422 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
30 | $32 | $122 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
25 | $256 | $1,037 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
21 | $89 | $336 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
15 | $83 | $347 |
| Functional task assessment A test that evaluates a patient's ability to perform specific functional tasks relevant to their environment. |
11 | $90 | $340 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,012
Total received (2018-2024)
Avg $1,859/year across 7 years
Top 23% in CA for clinical neurophysiology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
409
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,870 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$142 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,688
2023
$1,427
2022
$1,940
2021
$2,154
2020
$1,032
2019
$2,354
2018
$1,418
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$525
ABBVIE INC.
$398
Alexion Pharmaceuticals, Inc.
$335
PFIZER INC.
$224
EMD Serono, Inc.
$158
Neurelis, Inc.
$139
Grifols USA, LLC
$134
AstraZeneca Pharmaceuticals LP
$132
Novartis Pharmaceuticals Corporation
$112
Celgene Corporation
$57
SCILEX PHARMACEUTICALS INC.
$56
Otsuka America Pharmaceutical, Inc.
$52
CSL Behring
$50
Novo Nordisk Inc
$46
GlaxoSmithKline, LLC.
$40
Lilly USA, LLC
$40
LivaNova USA, Inc.
$27
Teva Pharmaceuticals USA, Inc.
$26
Genentech USA, Inc.
$24
Biogen, Inc.
$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$21
Lundbeck LLC
$20
Xeris Pharmaceuticals, Inc.
$18
Sumitomo Pharma America, Inc.
$17
ARGENX US, INC.
$16
Top 3 companies account for 46.8% of 2024 payments
All-time payments by company (2018-2024) ›
LivaNova USA, Inc.
$1,927
ABBVIE INC.
$985
UCB, Inc.
$859
Amgen Inc.
$737
Alexion Pharmaceuticals, Inc.
$657
Biogen, Inc.
$593
Grifols USA, LLC
$558
Allergan Inc.
$493
Nevro Corp.
$416
Novartis Pharmaceuticals Corporation
$386
Novo Nordisk Inc
$373
AbbVie Inc.
$288
EMD Serono, Inc.
$278
Celgene Corporation
$276
PFIZER INC.
$247
Alnylam Pharmaceuticals Inc.
$247
CSL Behring
$219
Allergan, Inc.
$190
Esperion Therapeutics, Inc.
$169
Teva Pharmaceuticals USA, Inc.
$164
Sunovion Pharmaceuticals Inc.
$151
Merz Pharmaceuticals, LLC
$142
Akcea Therapeutics, Inc.
$141
Bayer HealthCare Pharmaceuticals Inc.
$139
Neurelis, Inc.
$139
SCILEX PHARMACEUTICALS INC.
$135
IDORSIA PHARMACEUTICALS US INC
$134
AstraZeneca Pharmaceuticals LP
$132
GlaxoSmithKline, LLC.
$126
Acorda Therapeutics, Inc
$121
MERZ NORTH AMERICA, INC.
$112
SK Life Science, Inc.
$102
Lilly USA, LLC
$88
Boston Scientific Corporation
$86
Eisai Inc.
$83
Scilex Pharmaceuticals Inc.
$78
Flowonix Medical Incorporated
$67
Biohaven Pharmaceuticals, Inc.
$59
Janssen Pharmaceuticals, Inc
$58
Otsuka America Pharmaceutical, Inc.
$52
Promius Pharma LLC
$51
Sumitomo Pharma America, Inc.
$49
Arbor Pharmaceuticals, Inc.
$49
Bausch Health US, LLC
$48
Biohaven Pharmaceutical Holding Company Ltd.
$48
GENZYME CORPORATION
$46
MDD US Operations, LLC
$44
E.R. Squibb & Sons, L.L.C.
$44
TG THERAPEUTICS, INC.
$43
ARGENX US, INC.
$41
Merck Sharp & Dohme Corporation
$40
Supernus Pharmaceuticals, Inc.
$38
Medtronic Vascular, Inc.
$25
ARBOR PHARMACEUTICALS, INC.
$24
Genentech USA, Inc.
$24
Merck Sharp & Dohme LLC
$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$21
IBSA Pharma Inc.
$21
Amarin Pharma Inc.
$21
Lundbeck LLC
$20
Xeris Pharmaceuticals, Inc.
$18
ASSERTIO THERAPEUTICS, Inc.
$16
Upsher-Smith Laboratories LLC
$14
Hikma Pharmaceuticals USA
$12
Eyevance Pharmaceuticals LLC
$12
Collegium Pharmaceutical, Inc.
$12
Top 3 companies account for 29.0% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AFINITOR · AJOVY · APOKYN · APTIOM · Aimovig · Austedo XR · BELSOMRA · BOTOX · BOTOX - NEUROLOGY · BREZTRI · BRIUMVI · Briviact · DUOPA · Dayvigo · ELYXYB - celecoxib · EMGALITY · Edarbi · Endurant · GEMTESA · GENERAL PAIN MANAGEMENT · Gamunex-C · Gralise · Hizentra · Horizant · INBRIJA · JANUVIA · KESIMPTA · KEVEYIS · KEVZARA · Kerendia · Licart · MIGRANAL · MOUNJARO · Mavenclad · Mitigare · NEXLETOL · NURTEC ODT · ONPATTRO · Ocrevus Zunovo · Otezla · Ozempic · Prometra II · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · Rystiggo · SOLIRIS · SPRAVATO · Senza Spinal Cord Stimulation System · TECFIDERA · TEGSEDI · TRELEGY ELLIPTA · TROKENDI XR · TYSABRI · Tobradex ST · UBRELVY · ULTOMIRIS · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · Vascepa · XADAGO · XARELTO · XCOPRI · XEOMIN · XIFAXAN · Xeomin · ZAVZPRET · ZEPOSIA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Clinical neurophysiology physicians within 10 mi
24
Per 100K population
0.2
County median income
$87,760
Nearest hospital
GLENDALE MEM HOSPITAL & HLTH CENTER
0.9 mi
0.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gevorgyan is a clinical cardiology specialist, with above-average Medicare volume (top 9% in CA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gevorgyan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gevorgyan performed 659 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gevorgyan receive payments from pharmaceutical companies?
Yes. Dr. Gevorgyan received a total of $13,012 from 66 companies across 409 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gevorgyan's costs compare to other clinical neurophysiology physicians in Glendale?
Dr. Gevorgyan's average Medicare payment per service is $115. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gevorgyan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Clinical Neurophysiology Physicians in Glendale
Browse clinical neurophysiology physicians in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Clinical Neurophysiology Physicians in CA
Clinical neurophysiology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Clinical Neurophysiology Physicians in CA
Which CA clinical neurophysiology physicians receive the most from drug and device companies.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology